Blog Innovate UK

Organisations:
Innovate UK
Innovate UK

Ageing Society

Industrial Strategy Grand Challenge

Making the most of our longer lives

We’re living longer than ever before. A lot longer.

A baby boy born in 1916 in England could have expected to live to about 58; a baby boy born in 2016 can expect to see his 90th birthday. The massive increases in life expectancy we’ve seen in recent years have major implications for all areas of public life – and provide a huge opportunity for businesses and social enterprises.

Discover how we’re developing ground-breaking responses to an Ageing Society

The Government has set out an ambitious mission for the Ageing Society Grand Challenge: for people to enjoy five more years of healthy, independent living by 2035 while narrowing the gap between the experience of the richest and the poorest. The challenge needs to have the ambition to make a positive impact on the lives of millions of people within the next decade.

Industrial Strategy Challenge Fund - wave 3 shortlist

It’s been a busy few months since my last blog on the Industrial Strategy Challenge Fund (ISCF), and a lot has happened in that time. The second wave challenges are up and running, and you’ll hopefully have read the blogs …

Dramatic increase in the UK vaccine capability

I’m really excited to report that the largest single project in Wave 1 of the Industrial Strategy Challenge Fund Medicines Manufacturing portfolio – the Vaccines Manufacturing and Innovation Centre (VMIC) - is now under way.

Smart time to learn more about artificial intelligence

Image of robot with index finger pointing at temple

As Innovation Lead for Precision Medicine at Innovate UK I am sometimes asked about the best STEM subjects to study, usually by parents wanting to help their children select the best university courses. Something they’re really interested in, I have …

Helping Agri-Tech innovators stay ahead of the game

There are so many challenges facing agriculture these days that it’s hard to know where to start – new diseases, labour issues, hyper competitive supply chains, Brexit…?